Integrated BioPharma (OTCMKTS:INBP – Get Free Report) announced its earnings results on Friday. The company reported ($0.04) earnings per share (EPS) for the quarter, Zacks reports. Integrated BioPharma had a negative return on equity of 8.32% and a negative net margin of 3.43%.
Integrated BioPharma Stock Performance
Shares of OTCMKTS:INBP traded down $0.00 during midday trading on Friday, reaching $0.18. The company’s stock had a trading volume of 9,739 shares, compared to its average volume of 10,422. The firm has a market capitalization of $5.69 million, a price-to-earnings ratio of -2.62 and a beta of 0.40. Integrated BioPharma has a fifty-two week low of $0.14 and a fifty-two week high of $0.42. The firm has a 50 day moving average price of $0.17 and a two-hundred day moving average price of $0.21.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc is a health and wellness company focused on the development, manufacturing and distribution of nutritional supplements, vitamins, herbal products and related consumer health offerings. The company serves businesses and consumers seeking products in the dietary supplement and natural health categories.
Its activities have included contract manufacturing and private-label production, as well as the sale and distribution of finished nutritional and wellness products.
Further Reading
- Five stocks we like better than Integrated BioPharma
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
